T Lymphocytes and Autoimmunity

被引:96
作者
Khan, Uqba [1 ]
Ghazanfar, Hareem [1 ]
机构
[1] St John Hosp & Med Ctr, Detroit, MI 48236 USA
来源
BIOLOGY OF T CELLS, PT A | 2018年 / 341卷
关键词
PROTEIN-TYROSINE-PHOSPHATASE; LUPUS-ERYTHEMATOSUS PATIENTS; REDUCES DISEASE-ACTIVITY; MULTIPLE-SCLEROSIS; RHEUMATOID-ARTHRITIS; CELIAC-DISEASE; DOUBLE-BLIND; MOLECULAR-MECHANISMS; CLINICAL-APPLICATION; NEGATIVE SELECTION;
D O I
10.1016/bs.ircmb.2018.05.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
T lymphocytes play a central role in regulation of the immune system. Both effector and regulatory T cells work in equilibrium to provide optimal immune response against foreign pathogens. Normally, T cells do not react against self-antigens because of the presence of central and peripheral immunogenic tolerance. Central tolerance eliminates autoreactive naive T cells that develop in thymus by presenting them with self-antigens on the thymic cells. The autoreactive T cells that escape thymus are subjected to additional mechanisms such as clonal anergy, ignorance, and deletion. Moreover, the regulatory T cells (Tregs), specifically CD4(+)CD25(+)Foxp3(+) Tregs, exert a tight control over autoreactive B and T cell responses in the periphery. Failure of any one of these checkpoints can cause uncontrolled expansion of these self-reactive T cells leading to the development of autoimmune diseases. In this chapter we discuss the key role of T cells in the underlying pathogenesis of autoimmune responses. We review the role of T-cell receptor and signaling pathways including costimulatory pathways. We also review T cell inhibitory receptors such as programmed cell death protein 1 and cytotoxic T lymphocyte-associated antigen 4 and T cell-related important cytokines (interleukin [IL]-2, IL-6, IL-17, IL-7, and IL-33) involved in autoimmunity. Defects in genes responsible for T-cell regulation and function are also discussed in detail which forms the basis of many important autoimmune disorders. Various therapeutic measures that target T cells in the management of autoimmune diseases are also highlighted.
引用
收藏
页码:125 / 168
页数:44
相关论文
共 155 条
[1]   Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage [J].
Ahlmen, M. ;
Svensson, B. ;
Albertsson, K. ;
Forslind, K. ;
Hafstrom, I. .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) :230-233
[2]   The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance [J].
Akiyama, Taishin ;
Shimo, Yusuke ;
Yanai, Hiromi ;
Qin, Junwen ;
Ohshima, Daisuke ;
Maruyama, Yuya ;
Asaumi, Yukiko ;
Kitazawa, Juli ;
Takayanagi, Hiroshi ;
Penninger, Josef M. ;
Matsumoto, Mitsuru ;
Nitta, Takeshi ;
Takahama, Yousuke ;
Inoue, Jun-ichiro .
IMMUNITY, 2008, 29 (03) :423-437
[3]   A range of CD4 T cell tolerance: Partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis [J].
Akkaraju, S ;
Ho, WY ;
Leong, D ;
Canaan, K ;
Davis, MM ;
Goodnow, CC .
IMMUNITY, 1997, 7 (02) :255-271
[4]  
Albani Salvatore, 2016, TXB PEDIATRIC RHEUMA
[5]   T helper type 1 and 2 cytokines mediate the onset and progression of type I (insulin-dependent) diabetes [J].
Almawi, WY ;
Tamim, H ;
Azar, ST .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (05) :1497-1502
[6]   Common mechanisms of autoimmune diseases (the autoimmune tautology) [J].
Anaya, Juan-Manuel .
AUTOIMMUNITY REVIEWS, 2012, 11 (11) :781-784
[7]   Projection of an immunological self shadow within the thymus by the aire protein [J].
Anderson, MS ;
Venanzi, ES ;
Klein, L ;
Chen, ZB ;
Berzins, SP ;
Turley, SJ ;
von Boehmer, H ;
Bronson, R ;
Dierich, A ;
Benoist, C ;
Mathis, D .
SCIENCE, 2002, 298 (5597) :1395-1401
[8]   Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis [J].
Arend, William P. ;
Firestein, Gary S. .
NATURE REVIEWS RHEUMATOLOGY, 2012, 8 (10) :573-586
[9]   Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNγ-mediated B cell depletion [J].
Arens, R ;
Tesselaar, K ;
Baars, PA ;
van Schijndel, GMW ;
Hendriks, J ;
Pals, ST ;
Krimpenfort, P ;
Borst, J ;
van Oers, MHJ ;
van Lier, RAW .
IMMUNITY, 2001, 15 (05) :801-812
[10]   Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes [J].
Aronson, Ronnie ;
Gottlieb, Peter A. ;
Christiansen, Jens S. ;
Donner, Thomas W. ;
Bosi, Emanuele ;
Bode, Bruce W. ;
Pozzilli, Paolo .
DIABETES CARE, 2014, 37 (10) :2746-2754